Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Lemborexant-matched placebo
DRUG
2 trials
Sponsors
Eisai Inc.
Conditions
Insomnia
Irregular Sleep-Wake Rhythm Disorder
Phase 2
Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia
Completed
NCT03001557
Eisai Inc.
Irregular Sleep-Wake Rhythm Disorder
Start: 2016-12-20
End: 2020-04-17
Updated: 2021-05-17
Phase 3
Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)
Completed
NCT02783729
Eisai Inc.
Insomnia
Start: 2016-05-31
End: 2018-01-30
Updated: 2024-11-12
Related Papers
P.030 Impact of lemborexant on daytime sleepiness/alertness in participants with comorbid insomnia and mild obstructive sleep apnea
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
2025-06-01
P.031 Consistency of objective sleep maintenance data in Chinese and North American/European subjects with insomnia in lemborexant phase 3 studies
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
2025-06-01
0550 Lemborexant’s Effects on Rapid Eye Movement (REM) Sleep Architecture in Asian and Non-Asian Adults with Insomnia: Comparative Analysis from 3 Studies
SLEEP
2025-05-01
Effect of lemborexant on sleep architecture in participants with insomnia disorder and mild obstructive sleep apnea
Sleep Medicine
2024-12-17
7 citations
O030 Impact of lemborexant on daytime sleepiness/alertness in participants with comorbid insomnia and mild obstructive sleep apnea
SLEEP Advances
2024-10-01
Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease
Journal of Sleep Research
2024-09-12
3 citations
Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials
Drugs & Aging
2024-08-09
10 citations
Lemborexant and Daridorexant for the Treatment of Insomnia
The Journal of Clinical Psychiatry
2023-09-28
5 citations
P.054 Older subjects with insomnia disorder and comorbid pain at baseline: response to Lemborexant
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
2023-06-01
P.047 Effect of lemborexant on sleep architecture in subjects with comorbid insomnia and mild obstructive sleep apnea from a phase 3 trial
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
2023-06-01
P.053 Efficacy of lemborexant in adults with insomnia is supported by improvements in both objective and subjective measures
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
2023-06-01
0354 Effect of Lemborexant on Sleep Architecture in Subjects with Comorbid Insomnia and Mild Obstructive Sleep Apnea from a Ph 3 Trial
SLEEP
2023-05-01
2 citations
0351 Differential Effect of Lemborexant and Zolpidem on Wake Across the Night in Patients with Insomnia Disorder
SLEEP
2023-05-01
0407 Impact of Lemborexant on Daytime Ratings of Sleepiness/Alertness in Subjects with Insomnia Disorder and Baseline Sleepiness
SLEEP
2023-05-01
0224 Chronic change in sleep oscillation expression in older adults with insomnia with zolpidem or lemborexant and its effect on memory
SLEEP
2023-05-01
Effect of Lemborexant Treatment on Polysomnographic Sleep Measures in Older Adults with Insomnia and Objective Short Sleep Duration (P4-13.003)
Neurology
2023-04-25
Effect of Lemborexant on Early Morning Awakening in Elderly Subjects with Severe Problems with Waking Too Early (S6.010)
Neurology
2023-04-25
Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended-release for insomnia disorder subtypes defined based on polysomnographic findings.
2023-03-01
10 citations
0451 Effect of Lemborexant Treatment on Polysomnographic Sleep Measures in Older Adults with Insomnia and Objective Short Sleep
SLEEP
2022-05-25
0453 Lemborexant Exposure Is Independent of Race
SLEEP
2022-05-25
20 more papers not shown